TennesseeTennessee research institutions may join ibogaine trials under state and federal rules
Tennessee research institutions may take part in ibogaine trials and receive research funding, while treatment remains limited to trial settings under a licensed physician.
What it does
Tennessee research institutions may take part in ibogaine trials, including multistate studies, if they follow state and federal law and obtain any federally required authorization.
Ibogaine may be given only during a trial at a hospital or qualified research facility, under a Tennessee-licensed physician’s direction; participating institutions must follow federal-guided safety rules.
Health care providers, researchers, patients, and research institutions are protected from state controlled-substance criminal charges for trial conduct that federal law authorizes.
Argument forTennessee research institutions could join ibogaine trials and seek federal, private, or charitable funding for the research.
Argument againstFederal trial, physician, and safety rules may limit which Tennessee facilities can take part and how many patients can enroll.
More detail
Tennessee research institutions may take part in ibogaine clinical trials, including trials with other states. A research institution must be a Tennessee hospital, academic medical center, or college or university with clinical research capacity. All trial activity must follow applicable state and federal law. Federal investigational new drug authorization must be in place when federal law requires it.
Ibogaine may be given only in a clinical trial at a hospital or qualified research facility under a Tennessee-licensed physician’s direction. These limits apply to ibogaine given in Tennessee and to institutions conducting or joining federally authorized ibogaine trials. This chapter does not allow ibogaine to be given outside a clinical trial conducted under state and federal law. Institutions conducting or joining federally authorized trials must use patient screening and safety rules consistent with federal law, rules, and guidance.
Covered people and institutions are protected from state criminal charges under controlled substance laws for certain trial-related conduct. The protection covers health care providers, researchers, patients, and research institutions participating in a compliant ibogaine trial. The conduct must be part of an ibogaine trial that follows this chapter and federal law, and federal law must authorize the conduct. The protection applies only to state criminal liability under controlled substance laws for conduct that occurs as part of the trial.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed Senate
- Passed House
- To Governor
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2026
- May 27Pub. Ch. 1119Latest
- May 27Effective date(s) 05/22/2026
- May 22Signed by Governor Bill Lee.Became Law
- May 11Transmitted to Governor for action.To Governor
- May 7Signed by H. SpeakerMajor
- May 6Signed by Senate SpeakerMajor
- May 5Enrolled and ready for signaturesMinor
- Apr 23Placed on Senate Message Calendar 2 for 4/23/2026
- Vote recorded FLOOR VOTE: Motion to Concur House Amendment # 3 4/23/2026 Passed. Result: pass.Upper
- Apr 23Concurred, Ayes 28, Nays 0 (Amendment 3 - HA1253)Major
- Apr 22Subst. for comp. HB.Major
- Vote recorded FLOOR VOTE: REGULAR CALENDAR AS AMENDED PASSAGE ON THIRD CONSIDERATION 4/22/2026 Passed. Result: pass.Lower
- Apr 22Am. withdrawn. (Amendment 1 - HA0676)Minor
- Apr 22Am. withdrawn. (Amendment 2 - HA0952)Minor
- Apr 22H. adopted am. (Amendment 3 - HA1253)Major
- Apr 22Passed H., as am., Ayes 84, Nays 1, PNV 1Passed House
- Apr 20Rcvd. from S., held on H. desk.
- Apr 15Senate adopted Amendment (Amendment 2 - SA0944)
- Vote recorded FLOOR VOTE: as Amended Third Consideration 4/15/2026 Passed. Result: pass.Upper
- Apr 15Amendment withdrawn. (Amendment 1 - SA0597)
- Apr 15Passed Senate as amended, Ayes 31, Nays 1, PNV 1Passed Senate
- Apr 15Sponsor(s) Added.Minor
- Apr 15Engrossed; ready for transmission to HouseMinor
- Apr 13Placed on Senate Regular Calendar for 4/15/2026
- Apr 1Sponsor(s) Added.Minor
- Mar 31Recommended for passage with amendment/s, refer to Senate Calendar Committee Ayes 11, Nays 0 PNV 0
- Vote recorded SENATE FINANCE, WAYS AND MEANS COMMITTEE: Recommended for passage with amendment/s, refer to Senate Calendar Committee Ayes 11, Nays 0 PNV 0 3/31/2026 Passed. Result: pass.Upper
- Mar 31Sponsor(s) Added.Minor
- Mar 24Placed on Senate Finance, Ways, and Means Committee calendar for 3/31/2026
- Mar 4Recommended for passage with amendment/s, refer to Senate Finance, Ways, and Means Committee Ayes 9, Nays 0 PNV 0
- Vote recorded SENATE HEALTH AND WELFARE COMMITTEE: Recommended for passage with amendment/s, refer to Senate Finance, Ways, and Means Committee Ayes 9, Nays 0 PNV 0 3/4/2026 Passed. Result: pass.Upper
- Feb 25Action deferred in Senate Health and Welfare Committee to 3/4/2026
- Feb 25Placed on Senate Health and Welfare Committee calendar for 3/4/2026
- Feb 18Placed on Senate Health and Welfare Committee calendar for 2/25/2026
- Feb 5Passed on Second Consideration, refer to Senate Health and Welfare CommitteeMinor
- Feb 2Filed for introductionMinor
- Feb 2Introduced, Passed on First ConsiderationIntroduced
HealthcareMental HealthCriminal Justice